Biomarker evaluation in randomized trials: addressing different research questions

Stuart G. Baker

Type: Letter

Publication Date: 2014-09-04

Citations: 6

DOI: https://doi.org/10.1002/sim.6202

View Publication

Download PDF

Locations

PubMed Central - View
Europe PMC (PubMed Central) - View - PDF
PubMed - View
Statistics in Medicine - View

Similar Works

Action	Title	Year	Authors
+	Methods for Using Biomarker Information in Randomized Clinical Trials	2021	Jixiong Wang
+	Statistical Design and Evaluation of Biomarker Studies	2013	Kevin K. Dobbin
+ PDF Chat	Randomized Clinical Trials With Biomarkers: Design Issues	2010	Boris Freidlin Lisa M. McShane Edward L. Korn
+ PDF Chat	Design of clinical trials for biomarker research in oncology	2011	Sumithra J. Mandrekar Daniel J. Sargent
+ PDF Chat	Proceedings of the University of Pennsylvania 5th annual conference on statistical issues in clinical trials: Emerging statistical issues in biomarker validation for clinical trials	2013	Jonas H. Ellenberg Susan S. Ellenberg
+	Biomarker-Guided Trials	2022	Louise Brown A. L. Jorgensen Miranta Antoniou James Wason
+	Biomarker-Guided Trials	2021	Louise Brown A. L. Jorgensen Miranta Antoniou James Wason
+	Biomarker-Guided Trials	2022	Louise Brown A. L. Jorgensen Miranta Antoniou James Wason
+ PDF Chat	Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review	2017	Miranta Antoniou Ruwanthi Kolamunnage‐Dona Andrea Jorgensen
+	Biomarker-Based Clinical Trial Designs in Oncology	2016	Jianchang Lin
+	Biomarker in Clinical Trials	2010	Mark Chang
+ PDF Chat	Clinical Trials for Personalized Medicine: Design and Data Analysis	2022	Shigeyuki Matsui
+ PDF Chat	Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies	2019	Fang‐Shu Ou Ming-Wen An Amy S. Ruppert Sumithra J. Mandrekar
+	Value of Biomarker Expression for Randomized Clinical Trial Design: One (More) Missed Opportunity	2019	Francisco Vera-Badillo Andrew Robinson David M. Berman Christopher M. Booth
+ PDF Chat	Are randomized trials obsolete or more important than ever in the genomic era?	2013	John P. A. Ioannidis Muin J. Khoury
+	Integrating biomarker information within trials to evaluate treatment mechanisms and efficacy for personalised medicine. Clinical Trials 2013; 10:709?719.	2013	Graham Dunn Richard Emsley Hanhua Liu Sabine Landau
+ PDF Chat	Biomarker Discovery and Validation: Statistical Considerations	2021	Fang‐Shu Ou Stefan Michiels Yu Shyr Alex A. Adjei Ann L. Oberg
+	Biomarker-Guided Clinical Trial Designs	2018	Miranta Antoniou
+	Statistical Methodology for Design and Analysis of Trials with Biomarker-Guided Strategies	2017	Meilin Huang
+	Statistical Issues in Biomarker Research	2010	Daniel Holder Matthew J. Schipper

Works That Cite This (5)

Action	Title	Year	Authors
+	Biomarker-Guided Trials	2022	Louise Brown A. L. Jorgensen Miranta Antoniou James Wason
+	Biomarker-Guided Trials	2021	Louise Brown A. L. Jorgensen Miranta Antoniou James Wason
+ PDF Chat	Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes	2014	Stuart G. Baker Barnett S. Kramer
+	Biomarker-Guided Trials	2022	Louise Brown A. L. Jorgensen Miranta Antoniou James Wason
+ PDF Chat	Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review	2017	Miranta Antoniou Ruwanthi Kolamunnage‐Dona Andrea Jorgensen

Works Cited by This (4)

Action	Title	Year	Authors
+ PDF Chat	Evaluating Markers for Selecting a Patient's Treatment	2004	Xiao Song Margaret S. Pepe
+ PDF Chat	Statistics for Weighing Benefits and Harms in a Proposed Genetic Substudy of a Randomized Cancer Prevention Trial	2005	Stuart G. Baker Barnett S. Kramer
+ PDF Chat	Randomized reverse marker strategy design for prospective biomarker validation	2014	Kevin H. Eng
+	Biomarkers, subgroup evaluation, and clinical trial design.	2012	Stuart G. Baker Barnett S. Kramer Daniel J. Sargent Marco Bonetti